MJN_2010 Annual Report Final

download MJN_2010 Annual Report Final

of 16

Transcript of MJN_2010 Annual Report Final

  • 8/2/2019 MJN_2010 Annual Report Final

    1/16

    gwggvyyMead Johnson utrition nnual eport 2010

  • 8/2/2019 MJN_2010 Annual Report Final

    2/16

    tonourishtheworldschildrenfor

    thebeststartinlife

    tobetheworldsleading

    nutritioncoMpanyfor

    babiesandchildren

  • 8/2/2019 MJN_2010 Annual Report Final

    3/16

    Driving that perormance is a talented, diverse and efective global

    team o nearly 6,500 employees who draw inspiration every day

    rom our Mission to nourish the worlds children or the best start

    in lie. Underpinning that perormance is a powerul combination o

    actors and capabilities that makes Mead Johnson uniquely qualied

    to achieve its Vision to be the worlds leading nutrition company

    or babies and children:

    > the large and dynamic industry in which we operate, withvery avorable demographics and undamentals or prot-

    able growth;

    > a broad and balanced geographic ootprint, with a particularlystrong emerging-market presence;

    > a portolio o leading brands and over 70 products to meet thenutritional needs o inants and children;

    > the depth and strength o our science and our innovationpipeline;

    > our total commitment to quality and continuous improvement;> a diverse global leadership team and strong organizational

    capabilities, including those necessary to operate as a stand-

    alone independent company; and

    > our nancial strength demonstrated by outstanding marginsand excellent cash ow leading to superior shareholder value.

    Across our top measured markets, representing about 95 percent o our

    global sales, our singular ocus on pediatric nutrition has enabled us to

    achieve the number one position by value in inant ormula and the

    number two position by value in childrens nutritional supplements.

    In 2010, we delivered another year o record sales and earnings,with both growing at 9 percent, on a non-GAAP, constant dollar

    basis, versus 2009. Our sales growth was a particularly notable

    achievement, not only because it was the largest dollar increase

    over the last ve years, but also because it was based on a solid

    5 percent volume gain. This perormance was led by our Asia-Latin

    America segment, which grew 16 percent, excluding oreign exchange.

    In act, our sales outside the United States accounted or 68 percent

    o the Company total in 2010, up rom 65 percent in 2009.

    The perormance o our stock reects the trust that investors are

    placing in Mead Johnson and their condence in our business model,

    our strategies, our brands and our people. In 2010, MJN delivered

    just under a 45 percent total return to our shareholders, nearly

    triple the return generated by the S&P 500 Index.

    InternatIonal Growth enGIne The impressive growth

    across Asia and Latin America was led by China and Hong Kong, which

    together reported sales o $745 million in 2010, and now account

    or nearly a quarter o our global revenues. Strong, double-digit

    gains were also recorded across numerous other markets in this

    segment, including Malaysia and Singapore, as well key Latin American

    countries, including Mexico, Brazil, Colombia and Peru.

    Our business beneed signicantly rom our increased invest-

    ments behind advertising and promotion and in selective sales orce

    expansion. In 2010, we increased our spending on these demand-

    generation activities by 13 percent worldwide.

    We use a three-pillared demand-generation strategy reaching out

    directly to parents, communicating important nutritional science

    through healthcare proessionals, and partnering with retailers. We

    are communicating with consumers in new ways and through new

    media to help ensure that our superior science is well understood.

    We also broadened and strengthened our sales and distribution

    inrastructure in selected high-growth markets, most notably in China

    and Brazil. As a result o our ongoing Step Change Program in

    China, we now have ull sales and marketing resources in place in

    almost 200 cities nearly triple the number rom 2008, with another

    50 cities to be added over the coming year.

    Sales in Europe accounted or a small percentage o our globalbusiness and are heavily concentrated in specialty ormulas such

    as Nutramigen that are primarily distributed through pharmacies.

    These very specialized products reinorce Mead Johnsons reputa-

    tion or rigorous scientic research and nutritional expertise among

    leading scientists, regulators, healthcare proessionals and parents

    providing a solid oundation as we look to build our presence in

    the region.

    toourShareholderS,ColleaGueS&BuSIneSSPartnerS:

    THISPASTEAWASTHESECONDSINCEOUINITIALPUBLICOEINGANDOU

    ISTULLEAASACOMPLETELINDEPENDENTPUBLICCOMPANASEVIDENCEDBABOADSETOMEASUESMEADJOHNSONNUTITIONOLLOWED

    ITSSTONGDEBUTEAWITHANOUTSTANDINGPEOMANCEIN

  • 8/2/2019 MJN_2010 Annual Report Final

    4/162

    IMProVInG ProSPeCtS In the unIted StateS The United

    States remains our largest market, and we were able to stabilize

    our ull-year sales there, despite continued declines in births and

    overall ormula consumption. Our slight U.S. sales increase or 2010

    compares to a decline o 10 percent in 2009, and there was steady

    improvement in our business during the second hal o the year.

    We were able to grow share in a soer market on the strength o

    successul new product launches such as Enamil Premium with

    Natural Deense Dual Prebiotics and Enamil Premium Newborn

    as well as the introduction o our unique plastic tub and rell pouch

    packaging system. We also experienced some additional demand

    during the closing months o the year, resulting rom the market-

    place recall o a competitors product.

    eXPandInG FootPrInt In early 2010, we announced our agree-

    ment to partner with Almarai, the leading regional ood and dairy

    producer in the Middle East. By June, we had ormally established

    our new joint venture the International Pediatric NutritionCompany (IPNC), and by December, IPNC was launching its rst

    products into the Kingdom o Saudi Arabia. Although the new

    Almarai Enamil A+ is currently being imported, beore the end o

    2011, the venture will be producing products or amilies across the

    Gul Cooperation Council at a new, local, state-o-the-art production

    acility being built by Almarai.

    Brazil, another key development market or us, accelerated its growth

    in 2010. Due to a combination o our entry into the inant ormula

    market and the continuing strength and growth o our Sustagen

    brand o childrens nutritional supplements, Brazil was our astest-

    growing market on a percentage basis last year, moving into our top

    10 countries list and contributing to Latin America being our astest-

    growing region.

    Another market with tremendous, long-term potential is India.

    There, we are actively sharing our credentials and nutritional exper-

    tise with the local scientic, medical and regulatory communities,

    while also careully learning and gaining consumer insights. Overall,

    we remain in an investment mode slowly but steadily building our

    presence in the marketplace and looking or the best ways to make

    meaningul contributions to the growth and development o Indias

    inants and children.

    FInanCIal FoCuS and oPeratIonal dISCIPlIne Despite

    all this growth, and the substantial investments required to support

    it, we did not lose sight o the lean mindset that has served us so

    well over many years, paying close aention to operational eciency

    and overall cost control.

    One area o ocus, where we made solid progress in 2010, was man-

    aging controllable working capital. We were able to reduce average

    working capital to below 9 percent o sales in 2010, rom 12 percent

    in 2009, and almost 15 percent in 2008 signicantly beer than

    the 11.4 percent rate averaged by our peer companies.

    Another o Mead Johnsons historical strengths has been our ability

    to drive growth and productivity hand-in-hand. Although it gets

    tougher each year, we have a standing target o 3 percent in annual

    cost reductions, through various productivity initiatives and ecien-

    cies. In 2010, we were able to remove a record amount over $46

    million rom our product costs.

    We also beneed rom our November 2009 debt renancing,

    which cut our interest expense nearly in hal, as well as tax planning

    eforts that helped reduce our efective tax rate rom 30 percent

    in 2009 to below 29 percent in 2010.

    These nancial and operational eciencies acilitated our record

    earnings and helped to ofset a $24 million adverse impact rom two

    devaluations o the Venezuelan bolivar, cost increases or a number

    o key commodities, an $11 million incremental non-cash pension

    expense, and $18 million in cost overlaps or various shared services

    resulting rom the ongoing transition o IT, nance, and indirect

    procurement rom BMS to IBM.

    We completed the design o our Global SAP Technology Platorm

    during 2010, and went live with the new system in North America

    during the ourth quarter. This work is a critical step toward eliminat-

    ing the last o the remaining shared service overlaps by the end o

    2011 and ully leveraging the eciencies o our new global inra-

    structure in 2012 and beyond.

    herItaGe oF QualItY and InnoVatIon or more than a

    century, Mead Johnson has led the way in developing sae, high-

    quality, innovative products to help nourish the worlds children or

    the best start in lie. Ours is a business built on the trust o genera-

    tions o parents and healthcare proessionals, which is why we havesuch an uncompromising commitment to product saety and quality.

    Over the past ve years, more than $60 million o our capital invest-

    ments have been directed toward our quality systems and processes,

    and we have rigorous quality control capability at each o our seven

    manuacturing locations worldwide. This kind o commitment not

    only builds and strengthens the reputation o our products and

    brands, but also helps make the Mead Johnson logo a seal o approval

    or trust mark or consumers across the globe. Even with our impres-

    sive perormance record in this area, we are constantly looking or

    ways to urther raise quality standards.

    DESPITEALLTHISGOWTH

    WEDIDNOTLOSESIGHTOTHE

    LEANMINDSETTHATHASSEVED

    USSOWELLOVEMANEAS

  • 8/2/2019 MJN_2010 Annual Report Final

    5/16

    Perhaps nothing beer symbolizes our Companys ocus on contin-

    uous improvement and the advancement o quality and science in

    pediatric nutrition than the development o the Mead Johnson

    Pediatric Nutrition Institute (PNI). The PNI builds on our heritage o

    quality and innovation connecting the latest in scientic technology

    and research with cuing-edge manuacturing and quality processes,

    as well as developing powerul nutrition educational programs and

    materials or academics and healthcare proessionals.

    We have established a growing global network o PNI laboratories

    and acilities that put us at the oreront o pediatric nutrition science

    and quality. Over the past year, we have dedicated two new PNI

    locations one in the United States and one in Mexico and broken

    ground or a third in China that will open in November 2011. Together,

    these three acilities represent an investment o $50 million, above

    and beyond our baseline &D spending.

    But the Mead Johnson PNI goes ar beyond brick and mortar. It is

    a virtual, global entity through which we:

    > collaborate with academic institutions around the worldto conduct ground breaking research on the critical nutrition

    issues impacting children;

    > develop new products to meet the evolving needs o con-sumers and incorporating the most current nutritional science;

    > oster and develop strong relationships with organizationsin public health, pediatric medicine, dietetics and child care

    to collaborate on initiatives that positively impact the well-

    being o children; and

    > help bring experts rom various elds together to supportcontinuing education seminars and materials or health

    proessionals, sharing the results o research and teaching

    best practices in pediatric nutrition.

    eVerYthInG StartS wIth Good PeoPle O course, every-

    thing we do and have been able to accomplish begins with the talent

    and commitment o our people. We have been steadily increasing

    our capabilities and improving our management strength and depth

    not only driven by the need to achieve ull separation rom our

    ormer parent, but also by our desire to beer position ourselves to

    take ull advantage o current and uture business opportunities.

    It starts at the top, where we added to the strength and depth o

    our experienced Board o Directors, with the additions o KimberlyCasiano, Anna Catalano and, most recently, Celeste Clark. These

    three businesswomen bring with them an additional richness o

    perspective and global operating expertise that will be invaluable

    to our success.

    Similarly, as a result o our transition to ull corporate indepen-

    dence, we have added expertise in a number o key areas in 2010,

    including Tax, inance, External Afairs, Compensation & Benets

    among others. This additional bench strength has also acilitated

    the Boards and the Management Commiees ability to engage in

    more robust senior management development and succession plan-

    ning to support the organizations long-term continuity and growth.

    Another important step in strengthening the Company culture and

    team member engagement was the establishment o a unique set

    o Core Values to underpin our powerul Mission and Vision. These

    values dene what we stand or and help to guide us in terms o

    the kind o people we are seeking to aract, develop and retain in

    the Mead Johnson organization:

    > passionate pursuit o continuous improvement in all we do,

    > uncompromising commitment to scientic rigor and productquality,

    > unwavering integrity in every relationship we have andaction we take, and

    > an environment o openness, respect and high perormance.

    Speaking rom our collectively long experience with the Company,

    there has never been a more exciting time to be a part o Mead

    Johnson. The potential to grow the business sustainably and prot-

    ably and to meaningully advance the state o pediatric nutrition has

    never been more compelling.

    We sincerely appreciate the hard work and dedication o our Mead

    Johnson colleagues, the support o our partners, as well as the

    condence o our growing base o shareholders. We are tightly ocused

    on excellent execution o our strategic business plan to create addedvalue or all our key constituencies.

    Sincerely,

    Stephen W. Golsby James M. Cornelius

    President and Chairman o the Board

    Chie Executive Ocer

    THEPOTENTIALTOGOWTHEBUSINESS

    SUSTAINABLANDPOITABLAND

    TOMEANINGULLADVANCETHESTATE

    OPEDIATICNUTITIONHASNEVEBEENMOECOMPELLING

  • 8/2/2019 MJN_2010 Annual Report Final

    6/16

    11%PE EAGrowthrateForMeadJohnSonSSPendInGon

    r&dFroM2001throuGh

    2010,ContrIButInGto

    nearlY50notaBleProduCt,

    InGredIentandPaCKaGInG

    InnoVatIonSlaunChed

    durInGthattIMePerIod

    4

  • 8/2/2019 MJN_2010 Annual Report Final

    7/16

    SettInGtheStaGeFornewBreaKthrouGhS

    While the establishment o the Mead Johnson Pediatric Nutrition Institute

    (PNI) involves signicant investments in acilities and equipment, the

    real power o the PNI comes rom its ability to connect a virtual global

    network o leading scientic experts, research initiatives, white papers and

    data sources to urther enhance understanding o the signicant role

    early-lie nutrition plays in long-term health outcomes. The goal is then

    to efectively translate that understanding into beer nutritional products

    and practices or both current and uture generations.

    SCIentIFIC rIGor, unCoMProMISInG QualItYMEADJOHNSONSECOGNITIONASAWOLDWIDELEADEINPEDIATIC

    NUTITION ESULTS OM THE COMBINATION O OU PASSIONATE

    COMMITMENTTOSCIENCEBASEDESEACHANDOUDEEPINSIGHTS

    INTOTHENEEDSOCHILDENANDTHEIPAENTS

    In 2010, we introduced close to a dozen signicant

    product, packaging and ingredient innovations that helped

    advance our mission to nourish the worlds children or

    the best start in lie.We were the rst to help inants get the doctor-recom-

    mended amount o vitamin D through ormula during the

    crucial rst three months o lie with the introduction

    o Enamil Premium Newborn in the United States

    part o a staged approach that takes into account the

    varying nutritional needs o inants and children as they

    grow and develop.

    Support o healthy immune systems was the driving orce

    behind the launch o a new, patented prebiotic blend in

    inant ormulas in the United States and Mexico, as well as

    the addition o the immune response-enhancing ingre-

    dient, beta-glucan, to childrens products in a number

    o Asian and Latin American markets.

    Also new in 2010 was Enamil Premature High-Protein. This

    highly specialized ormulation is based on extensive nutri-

    tional research by leading neonatologists and reects our

    commitment to provide proper nutrition to the most

    ragile and vulnerable among the inant population.

    O course, our innovation eforts extend beyond nutri-

    tional and health benets. The introduction o our unique

    plastic tub and rell pouch packaging system ofers addi-

    tional value and convenience to parents, while also

    having a positive impact on the environment, as a result

    o reduced packaging usage and increased recyclability.Importantly, the driving orce behind all o these cre-

    ative eforts is our outstanding &D team. epresenting

    a wide range o scientic and medical specialties, they

    bring a sophisticated, global perspective as well as

    curiosity and passion to their work, as they expand

    the potential benets o pediatric nutrition every day.

    ully integrated with our innovation activities are rigor-

    ous programs designed to ensure the saety and quality

    o our products. Mead Johnson embeds quality through-

    out the product liecycle rom the lab bench to the

    production line and throughout the distribution process.

    The rigor begins with ingredient quality review and

    continues through technology assessment, specication

    development, process qualication and long-term sta-

    bility studies. We understand the signicance o the trust

    placed in us and our products by healthcare proes-

    sionals and parents around the world and recognize

    that constant vigilance is required to continue earning

    that trust.

  • 8/2/2019 MJN_2010 Annual Report Final

    8/16

    roBuStGrowth,ContInuouSIMProVeMentBEVEOBJECTIVEMEASUESALESEANINGSMAKETSHAE

    ETUN TO SHAEHOLDES WAS AN IMPESSIVE EA BUT

    MEAD JOHNSONS SUCCESS ETENDED A BEOND THE NUMBES

    SIGNIICANT POGESS WAS ALSO MADE INCEASING EICIENCIES

    LEVEAGINGESOUCESANDEPANDINGCAPABILITIES

    Mead Johnson operates in a highly competitive market-

    place and continues to ace a challenging economic

    environment. So, as gratiying as the 2010 results were,we recognize the need to continuously raise the bar on

    perormance in order to meet the challenges o the

    new year, exceed the expectations o customers, and

    ully capitalize on identied opportunities.

    Success is not just keeping up with the competition it

    is about creating and sustaining competitive advantage.

    In order to truly win, we need to grow aster than the

    category and increase our separation rom competing

    brands and companies.

    While we must continue ofering high quality products

    with superior benets, we also need to nurture thebrands behind them. Mead Johnson is investing at

    record levels behind its most important brands like

    Ena while striving to make that spend as efective

    and ecient as possible.

    As we have increased our marketing investments, we

    have careully measured the results in order to ensure

    that our eforts are impacting their intended targets

    efectively, driving consumers to choose our brands

    bolstering their image and our sales perormance.

    In 1959, Enamil inant ormula was launched; and over the

    past ve decades, we have transormed Ena into a

    powerhouse brand. By understanding consumers needsand concerns and aligning them with relevant benets

    built into our products under the Ena banner we have

    extended the brands equity across multiple geographies

    and stages o development. Today, Ena is a multi-billion

    dollar global brand trusted to deliver brain and immu-

    nity benets and healthy growth through supplements

    or pregnant and lactating women, inant ormula, ollow-

    on ormulas, growing-up milks and school-age milks.

    We are constantly looking to enhance the reason to

    believe in all our brands including the Mead Johnson

    brand to reinorce and extend the trust and preer-

    ence they have earned among healthcare proessionals

    and parents worldwide. To help us best leverage these

    valuable corporate assets, we have added to the capac-

    ity and capabilities o our Global Marketing team. They

    play a key role in aligning brand and innovation strategy

    to help deliver a winning new product pipeline, grounded

    in consumer insights and the latest science. Also, in col-

    laboration with regional marketing leaders, they cra

    powerul messaging across a variety o media to help

    ensure that our superior products, benets and science

    are widely recognized and well understood.

    2006

    2007

    2008

    2009

    2010 $2.42

    $2.23

    $1.90

    $1.72

    $1.63

    6

    2006

    2007

    2008

    2009

    2010 $3.1

    $2.8

    $2.8

    $2.5

    $2.3

    netSaleS*[INBILLIONS] earnInGSPerShare*

    *Non-GAAPresultsshown.PleaserefertotableonthebackinsidecoverforreconciliationtoGAAPdata.

  • 8/2/2019 MJN_2010 Annual Report Final

    9/16

    17%

    SaleSGrowthIn2010

    FortheenFaBrand

    worldwIde(enFaMIl,

    enFaMaMa,enFalaC,

    enFaPro,enFaGrow,

    enFaKIdandenFaSChool)

  • 8/2/2019 MJN_2010 Annual Report Final

    10/168

    17%BaSelInereduCtIonIn

    naturalGaSConSuMPtIon

    atMeadJohnSonFaCIlItIeS

    worldwIdeFroM2001

    throuGh2009

  • 8/2/2019 MJN_2010 Annual Report Final

    11/16

    unwaVerInGInteGrItY,CarInGSuPPortEVE DA MEAD JOHNSON NUTITION EMPLOEES WOLDWIDE

    LOOK TO THE COMPANS MISSION AND VISIONO INSPIATION

    TOEINOCEWHWEAEINBUSINESSANDWHATWEASPIETO

    ACHIEVEANDTOOUSETOCOEVALUESTOEINOCEWHAT

    WEBELIEVEINANDWHATISESSENTIALOTHELONGTEMGOWTH

    ANDSUCCESSOOUBUSINESSANDCULTUE

    Linking with and providing a oundation or these CoreValues is the Mead Johnson Standards o Business

    Conduct and Ethics, which embody our commitment

    to not only complying with the leer o the law, but also

    adhering to the highest principles o moral and ethical

    behavior. These standards and values guide us and help

    ensure that we act with integrity and respect the trust

    placed in us by our customers, consumers, ellow employ-

    ees, shareholders, regulatory agencies, suppliers, part-

    ners and the communities in which we live and work.

    Even beyond making these right choices, we are com-

    mied to always doing the right thing as a company.

    Mead Johnson has been a responsible corporate citizenor more than a century, and we are resolved to build

    upon that heritage as we grow our global business

    protably and sustainably over time.

    As part o our transition to ull corporate independence,

    we have been taking a closer look at how beyond

    living out our Mission to nourish the worlds children or

    the best start in lie we can help ensure that the world

    in which they grow up is a lile cleaner, healthier and

    beer place to be. As a result o this examination, we

    have rened and ormalized our approach to Corporate

    Social esponsibility (CS).

    awIn-wInForConSuMerSandtheenVIronMent

    Our new Enamil reusable tub and rell system not only ofers

    increased value and convenience or consumers, but also ofers

    the potential or signicant reductions in the carbon ootprint o the

    packaging involved. Under a typical scenario, use o our recyclable

    tub and environmentally riendly rell boxes involves up to 35 per-

    cent less packaging materials, 60 percent less energy usage and

    50 percent less greenhouse gas emissions.

    OurVs

    PASSIONATEPUSUITOCONTINUOUS

    IMPOVEMENTINALLWEDO

    UNCOMPOMISINGCOMMITMENT

    TOSCIENTIICIGOAND

    PODUCTUALIT

    UNWAVEINGINTEGITIN

    EVEELATIONSHIPWEHAVE

    ANDACTIONWETAKE

    ANENVIONMENTOOPENNESS

    ESPECTANDHIGHPEOMANCE

  • 8/2/2019 MJN_2010 Annual Report Final

    12/16

    Our CS strategy is built along three simple elements:

    >Svig Mkpcostering trust through our commitment to

    the highest business standards and best nutri-

    tional quality

    >Pcig evimCommied to a more sustainable business in or-

    der to preserve resources or uture generations

    >nig CmmiisWorking to create communities where amilies

    and individuals can grow and prosper

    In addition to holding to the standards and values noted

    above, Serving the Marketplace includes our commit-

    ments to quality assurance, market responsiveness and

    responsible marketing, as well as the nutritional scienceand knowledge-sharing initiatives o the Mead Johnson

    Pediatric Nutrition Institute.

    elative to Protecting the Environment, we have iden-

    tied some key ocus areas or our eforts energy

    and water utilization, emissions and waste management,

    reduction o packaging impact, and responsible sourcing

    o raw materials. These are all aspects o our operations

    where we have had past success, but still see additional

    opportunities or improvement. We are currently in the

    process o establishing various corporate multi-year

    environmental targets and ensuring that we have the

    appropriate systems and measures in place to track our

    perormance and progress against those goals over time.

    In support o that, over the past year, we have imple-

    mented a global waste/resource management strategy;

    launched our new Environmental, Health & Saety

    Management soware; and ormed a cross-unctional

    Eco-Smart Sustainable Packaging Workgroup.

    The third pillar o our CS program Nurturing Com-

    munities encompasses the way we support people

    both inside and outside the organization. Internally,

    it reers to our eforts to provide a air and sae work-

    place and to encourage employee engagement, diversity

    and inclusion. Externally, it addresses how we seek to

    maximize the positive impact o local investment across

    our broad-based, global enterprise and how we giveback to the communities in which we operate in terms

    o philanthropy and volunteer involvement.

    Over the past year, we have taken a number o actions to

    bolster our philanthropic activities, including the estab-

    lishment o the Mead Johnson Nutrition oundation.

    We also have launched a program to match charitable

    donations by employees with Company contributions.

    In general, we are looking to create a more global plat-

    orm rom which to carry on our longstanding eforts to

    support inants and children in especially ragile and

    vulnerable circumstances. We want to build upon our

    well-established charitable programs such as eeding

    Hope, Helping Hands, aising Lives, One Kilogram o

    Hope, Journey o Love, and those addressing metabolic

    and rare inant diseases as well as some newer eforts

    to support orphanages and children who dont have

    parents to provide them with the best start in lie.

    We are looking to utilize the ull range o assets we have

    at our disposal to make a positive diference in our local

    communities and the world leveraging not only nan-

    cial contributions, but also our scientic capabilities

    and deep insights into pediatric nutritional needs, as well

    as our very talented and passionate employees. Like our

    global business, we want our positive social impact and

    ties to our communities to grow stronger every day.

    10

    MaKInGadIFFerenCewIthMetaBolICdISorderS

    Phenylketonuria (PKU) is a disorder that has been a ocus or MJN around the

    world. In China, in cooperation with the Ministry o Health, we initiated a multi-

    year, $4-million efort to increase PKU awareness and newborn screening, train

    local healthcare proessionals on PKU management, and donate specialty ormula

    to help meet the nutritional needs o hundreds o PKU inants rom poverty

    stricken amilies. Under the China oundation or Poverty Alleviation, we have

    also established and provided initial unding or the Bloom o Hope und to

    encourage broader involvement in PKU philanthropy.

  • 8/2/2019 MJN_2010 Annual Report Final

    13/16

    163M I L L I O NtheeStIMatednuMBeroF

    orPhanSanddISPlaCed

    ChIldrenworldwIdea

    PoPulatIonthatFItSSQuarel

    IntoMeadJohnSonSPhIlan-

    throPICFoCuSoFSuPPortInG

    YouthInPartICularlYFraGIle

    andVulneraBleCIrCuMStanCe

  • 8/2/2019 MJN_2010 Annual Report Final

    14/16

    MANAGEMENTCOMMITTEE[picturedL-R]

    back row

    Peter G. Leempue

    SeniorVicePresidentandChiefFinancialOcer

    William C. PPool

    SeniorVicePresident,

    GeneralCounselandSecretary

    Dirk Hondmann, Ph.D.SeniorVicePresident,

    GlobalResearchandDevelopment

    James Jefrey Jobe

    SeniorVicePresident,GlobalSupplyChain

    fron row

    Peter Kasper Jakobsen

    President,Americas

    Stephen W. Golsby

    PresidentandChiefExecutiveOcer

    Lynn H. Clark

    SeniorVicePresident,HumanResources

    Charles M. Urbain

    President,AsiaandEurope

    BOADODIECTOS[picturedL-R]

    op row

    James M. Cornelius

    ChairmanoftheBoard

    Chairmanand

    FormerChiefExecutiveOcer,

    Bristol-MyersSquibb

    Steven M. Altschuler, M.D. 2, 4

    ChiefExecutiveOcer,

    TheChildrensHospitalofPhiladelphia

    Howard B. Bernick 1, 2

    President,BernickAdvisoryLimited,

    FormerPresidentandChiefExecutiveOcer,

    AlbertoCulverCompany

    Kimberly A. Casiano 1, 3

    FormerPresidentandChiefOperatingOcer,

    CasianoCommunicationsInc.

    Ellio Sigal, M.D., Ph.D. 4

    DirectorandExecutiveVicePresident,

    ChiefScienticOcerandPresident

    ResearchandDevelopment,

    Bristol-MyersSquibb

    obert S. Singer 1, 3

    FormerChiefExecutiveOcer,

    BarillaHolding,S.p.A.

    1. Audit Commiee

    2. Compensation and Management Development Commiee

    3. Nominating and Corporate Governance Commiee

    4. Nutrition Science and Technology Commiee

    Anna C. Catalano 2, 3

    FormerPresident,AmocoOrientOilCompany

    ChinaandGroupVicePresident

    Marketing,BPplc

    botom row

    Celeste A. Clark 4

    SeniorVicePresident

    GlobalPublicPolicyandExternalRelations

    andChiefSustainabilityOcer

    TheKelloggCompany

    Stephen W. Golsby

    PresidentandChiefExecutiveOcer,

    MeadJohnsonNutritionCompany

    Peter G. atclife 1, 3

    DirectorandFormerChiefExecutiveOcer,

    P&OPrincessInternationalDivision,

    CarnivalCorporation

    12

  • 8/2/2019 MJN_2010 Annual Report Final

    15/16

    Mead Johnson utrition ompan

    2701 atriot bouleard, 4th loor

    glenie, llinois 60026

    847.832.2420

    .meadjohnson.com

    kxg

    Mead Johnson utrition ompan

    is listed and traded on the e yor

    toc chane under the ticersmol MJ.

    vy

    iidends on Mead Johnson common

    stoc are declared the board of

    irectors on a quarterl asis and are

    tpicall paid on or aout the rst da

    of Januar, pril, Jul and ctoer.

    g

    g

    by Mellon hareoner erices

    480 washinton bouleard

    Jerse it, e Jerse 07310

    ontact enter:

    nited tates

    866.207.6566

    utside the nited tates

    201.680.6578

    or the hearin impaired ()

    800.231.5469

    .nmellon.com/shareoner

    b

    gM

    eloie & ouche

    1djustment of our 2006 to 2008 results for comparailit to our 2009 results include operatin model chanes primaril in brazil and urope. n brazil, our ailit to operate as a ne stand-alone susidiar as delaed fromeruar 2009 to late eptemer 2009. urin that time, bM distriuted and recorded sales for our products and e conducted maretin actiities. n urope, e hae transitioned to a third-part distriutor model ith bM

    temporaril serin as our distriutor. his reduced net sales the amount of the distriutors marin and loered costs for the distriution-related epenses.2djustments for and other separation costs, seerance and other costs, leal, selement and related costs, -related costs and ain on asset sale.3djustments to conform numer of shares outstandin to the post- period.

    g

    (et ales /arnins er hare) $2,345.1 $2,576.4 $2,882.4 $2,826.5 $3,141.6

    Operatingmodelchanges1

    (35.9) (35.9) (35.9) Specieditemsbeoreincometaxes2

    Incometaximpactonitemsabove

    Efectonewlyissuedshares3

    djusted non-g results $2,309.2 $2,540.5 $2,846.5 $2,826.5 $3,141.6

    $2.34 $2.49 $2.32 $1.99$2.20

    (0.46) (0.45) (0.1 1 ) 0.400.35

    0.14 0.10 0.08 (0.12)(0.13)

    (0.39) (0.42) (0.39) (0.04)

    $1.63 $1.72 $1.90 $2.23$2.42

    n millions ecept per share data)

    g

    gM

    EnamilGentlease

    EnamilPremature

    EnamilAR

    EnalacPremature

    EnalacAR

    Enacare

    MJNMetabolics

    Nutramigen

    NutramigenAA

    NutramigenLGG

    Olac

    Pregestimil

    ProSobee

    Alacta

    Enamil

    EnamilPremium

    EnamilA+

    EnamilNewborn

    Enalac

    EnalacA+

    Enapro

    EnaproA+

    EnaproPremium

    M

    *orcommoneedingproblems,allergies,intolerance,prematurity,metabolicdisorders

    kyb

    My/*

    2006 2007 2008 2009 2010 2006 2007 2008 2009 2010

    Alacta

    Cal-C-Tose

    ChocoMilk

    Enagrow

    EnagrowPremium

    EnagrowA+

    EnakidPremium

    EnakidA+

    EnaschoolA+

    Lactum

    Sustagen

    gwgMk

    Expecta

    EnaMamaA+

    Poly-Vi-Sol

    Tri-Vi-Sol

    Fer-In-Sol

    D-Vi-Sol

    vM/M

  • 8/2/2019 MJN_2010 Annual Report Final

    16/16

    gwg gvy y